TL;DR Tirzepatide is a dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly, while semaglutide is a GLP-1 receptor agonist only, made by Novo Nordisk
Las pastillas de Wegovy son una forma oral de semaglutida para el control del peso
People with overweight or obesity may benefit more from Ozempic
However, insurance does not cover compounded medications, so patients pay out of pocket
Liraglutide, marketed under the brand names Victoza for diabetes management and Saxenda for weight management, is a versatile GLP-1 receptor agonist with a distinct focus on weight loss
Semaglutide is exclusively patented by Novo Nordisk, and the drugmaker does not supply the ingredient to outside groups, which has raised questions about what other companies are selling to consumers